The role of antimicrobial, antigenic, and complex antimicrobials in the prevention of fungal disease

The concept of health management is increasingly embedded in people's minds, and scientific health knowledge is becoming increasingly popular and worthy of public attention. The role of microbes in the pathogenesis and prevention and treatment of gastrointestinal and oral malignancies is increasingly being discussed and studied. There is a growing body of evidence supporting the importance of specific types of microbes and their products in the pathogenesis and prevention and treatment of certain cancers.

This review summarizes recent studies on the use of probiotics (including Bifidobacteria, Lactobacilli, etc. ) and their products (including postbiotics, such as β-butyrate, etc. ) and synbiotics in combination with prebiotics and combination formulations) in areas such as cancer prevention and progression, adverse reactions to anti-cancer drugs, cancer prevention and progression, cancer prevention and progression, cancer prevention and progression, and cancer prevention and progression.

Clinical studies have shown the benefits of these pre-treatment drugs, especially in preventing and alleviating gastrointestinal symptoms and complications of post-operative infections, as well as inflammatory retinal injury (including oral retinopathy) in patients with lung cancer. It should be pointed out that the above information is based on international public research and is not a clinical recommendation for HealthCop. If you have any health questions, please consult a professional medical professional.